Apellis Pharma is attracting interest from big pharma, Bloomberg reported.

Published Date: 07 Apr 2023

Apellis is talking to consultants to consider options and will seek a partnership or licensing agreement for certain retail products...

Read Full News

Latest News

Gene-Agnostic Therapy Sees 3-Year Gain in Severe Vision Loss

A treatment that targets dysfunctional photoreceptors regardless of the underlying genetic mutation leads to improved functional vision in advanced severe vision loss.

Navigating Sustained Delivery in nAMD: An Interactive Clinical Decision-Making Simulation

Navigating Sustained Delivery in nAMD: An Interactive Clinical Decision-Making Simulation

Navigating Sustained Delivery in DME: An Interactive Clinical Decision-Making Simulation

Navigating Sustained Delivery in DME: An Interactive Clinical Decision-Making Simulation

Beyond Intravitreal Injections: Advancing Retinal Vascular Disease Care With Sustained Delivery Therapies

Beyond Intravitreal Injections: Advancing Retinal Vascular Disease Care With Sustained Delivery Therapies

Focus Aligned: Patient Selection and Counseling for Pharmacologic Presbyopia Therapies

Focus Aligned: Patient Selection and Counseling for Pharmacologic Presbyopia Therapies

Focus Reengineered: Mechanisms and Clinical Data for Pharmacologic Presbyopia Therapies

Focus Reengineered: Mechanisms and Clinical Data for Pharmacologic Presbyopia Therapies

Todays Updates

EMA Backs Breast Cancer SERD After FDA No Vote

The recommendation follows phase 3 data showing longer progression-free survival when patients switched to camizestrant plus a CDK4/6 inhibitor.

Datopotamab Deruxtecan Earns New Breast Cancer Indication

The antibody drug conjugate was approved by the FDA for certain patients with triple-negative breast cancer.

Todays Updates

EMA Backs Breast Cancer SERD After FDA No Vote

The recommendation follows phase 3 data showing longer progression-free survival when patients switched to camizestrant plus a CDK4/6 inhibitor.

Datopotamab Deruxtecan Earns New Breast Cancer Indication

The antibody drug conjugate was approved by the FDA for certain patients with triple-negative breast cancer.

Latest News

A treatment that targets dysfunctional photoreceptors regardless of the underlying genetic mutation leads to improved functional vision in advanced severe vision loss.

Navigating Sustained Delivery in nAMD: An Interactive Clinical Decision-Making Simulation

Navigating Sustained Delivery in DME: An Interactive Clinical Decision-Making Simulation

Beyond Intravitreal Injections: Advancing Retinal Vascular Disease Care With Sustained Delivery Therapies

Focus Aligned: Patient Selection and Counseling for Pharmacologic Presbyopia Therapies

Focus Reengineered: Mechanisms and Clinical Data for Pharmacologic Presbyopia Therapies

News All Time

One GLP-1 Drug May Be Better Than Rivals for Glaucoma Risk

But it's not time to prescribe tirzepatide outside current indications, expert says

Color Blindness and Bladder Cancer: A Bad Combination for Survival?

Study suggests inability to identify blood in urine may delay diagnosis and reduce survival

Cardiovascular Risk Score Shows Value in Predicting Future Eye Disease

The score is commonly calculated in primary care

People, Faces Appeared Smaller Than Usual in Patient's Rare Case

63-year-old had an atypical cause of Alice in Wonderland Syndrome

Contaminated Water Blamed for 10 Deaths; FDA Rejections; Mammograms for Heart Risks?

Health news and commentary gathered by MedPage Today staff

FDA OKs More Eye Drops That Can Replace Reading Glasses

Once-daily carbachol/brimonidine tartrate significantly improves aging-related vision loss

Sleeping With Two Pillows May Raise Internal Eye Pressure in Glaucoma

Stacked pillows alter the neck position and may compress the jugular, researchers suggest

Teen Boy Grows a Tooth Between Eyelid and Eyebrow

The 16-year-old underwent surgery to remove an ectopic canine tooth in left eye's superior orbit

Study Adds Fuel to the Debate Over Cataract Surgery and Wet AMD

Earlier concerns about surgery accelerating AMD progression likely overstated, researcher says

Hospital Had Ties to Epstein; Naked Knifeman at Eye Doctor; Health Department Probed

Health news and commentary gathered by MedPage Today staff

Some Blind Fans to Experience Super Bowl With Tactile Device That Tracks Ball

About 10 blind and low-vision fans will have an opportunity to use the technology

CDC Study Warns of Vision-Threatening Eye Infections After Laser Surgery

Three patients at New York City clinic developed fungal keratitis caused by a mold

Dry Eye: Handmaiden to Many Autoimmune Conditions, Not Just Sjogren's Disease

Taiwanese study puts numbers to common but poorly studied phenomenon

Retinopathy Risk With Long-Term HCQ Treatment Detailed in Meta-Analysis

Eye damage remains uncommon after 15 years, but certain factors increase the risk

Glaucoma Checks in Primary Care; Wastewater to Screen for Colorectal Cancer

Also in TTHealthWatch: new cholesterol management guidelines

Wegovy May Carry Highest Risk of Blinding Condition Among GLP-1 Drugs

First evidence of formulation-specific difference, significantly higher in men than women

Recommended News For You

Safe and acceptable telehealth suicide prevention program.

AI Breath Test IDs Cancers; More Grief for Prior Auth; Imatinib Discoverer Resigns

Limited Benefit from New Drugs; Significant Increase in Drug Prices; AI Boost for Mammo Results.

Housing aid linked to lower medical financial hardship among US renters with cancer

High Rate of Surgical Success in Complex NSCLC With Neoadjuvant Chemoimmunotherapy

According to research, the mineralization of the bone matrix controls the growth of tumor cells.

Herpes virus-based vaccine shows promise in targeting tumors without side effects

Recommended Articles For You

Uncovering the Hidden Signs: How to Recognize the Early Symptoms of Colon Cancer 

Navigating the Complexity of Peritoneal Carcinomatosis: A Guide for Patients and Caregivers 

Unlocking the Potential of Hemin: A Novel Approach to Health and Wellbeing 

Amivantamab Plus Chemotherapy Outperforms Standard Care in Post-Osimertinib NSCLC 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Potential targets for treating the most common type of liver cancer in children have been identified by a collaborative study.

2.

Study identifies new approach to protect the brain during radiation therapy

3.

While most cancer screenings won't prolong lives, there are still good reasons to continue screening.

4.

Chemo-Free Quadruplet Shows Promise as DLBCL's First Therapy.

5.

Radiation therapy for patients with breast cancer

1.

Radiation in Oncology: Advances, Applications, and Accessibility

2.

The Next Generation of Precision: How Multi-Specific Antibodies are Redefining Oncology's Future - A 2025 Review

3.

Cracking Oncology Drug Resistance: New Strategies to Overcome Challenges in Modern Cancer Therapy

4.

Unlocking the Secrets of Neutrophils: Exploring Their Role in Immune Defense

5.

Precision Oncology: Personalized Medicine Shaping the Future of Cancer Care

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part II

2.

Recent Data Analysis for First-Line Treatment of ALK+ NSCLC

3.

Navigating the Complexities of Ph Negative ALL - Part XIII

4.

Navigating the Complexities of Ph Negative ALL - Part IV

5.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VIII

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot